TY - STD TI - Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69:Epub 2019 Jan 8. ID - ref1 ER - TY - JOUR AU - Boyd, L. K. AU - Mao, X. AU - Lu, Y. J. PY - 2012 DA - 2012// TI - The complexity of prostate cancer: genomic alterations and heterogeneity JO - Nat Rev Urol VL - 9 UR - https://doi.org/10.1038/nrurol.2012.185 DO - 10.1038/nrurol.2012.185 ID - Boyd2012 ER - TY - JOUR AU - Cary, K. C. AU - Cooperberg, M. R. PY - 2013 DA - 2013// TI - Biomarkers in prostate cancer surveillance and screening: past, present, and future JO - Ther Adv Urol VL - 5 UR - https://doi.org/10.1177/1756287213495915 DO - 10.1177/1756287213495915 ID - Cary2013 ER - TY - JOUR AU - Saini, S. PY - 2016 DA - 2016// TI - PSA and beyond: alternative prostate cancer biomarkers JO - Cell Oncol (Dordr) VL - 39 UR - https://doi.org/10.1007/s13402-016-0268-6 DO - 10.1007/s13402-016-0268-6 ID - Saini2016 ER - TY - JOUR AU - Walter, L. C. AU - Bertenthal, D. AU - Lindquist, K. AU - Konety, B. R. PY - 2006 DA - 2006// TI - PSA screening among elderly men with limited life expectancies JO - JAMA VL - 296 UR - https://doi.org/10.1001/jama.296.19.2336 DO - 10.1001/jama.296.19.2336 ID - Walter2006 ER - TY - STD TI - EAU Guidelines. Edn. presented at the EAU Annual Congress Barcelona 2019. ISBN 978-94-92671-04-2. ID - ref6 ER - TY - STD TI - Abreu AL. The pillars for sustained growth of magnetic resonance imaging pathway for prostate Cancer diagnosis: quality, Reproducibility, Accessibility, Cost Effectiveness, and Training. Eur Urol. 2020. ID - ref7 ER - TY - STD TI - Venderink W, Bomers JG, Overduin CG, et al. Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 3: Targeted Biopsy. Eur Urol. 2019. ID - ref8 ER - TY - JOUR AU - Cooperberg, M. R. AU - Broering, J. M. AU - Carroll, P. R. PY - 2009 DA - 2009// TI - Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis JO - J Natl Cancer Inst VL - 101 UR - https://doi.org/10.1093/jnci/djp122 DO - 10.1093/jnci/djp122 ID - Cooperberg2009 ER - TY - JOUR AU - D'Amico, A. V. AU - Whittington, R. AU - Malkowicz, S. B. PY - 1998 DA - 1998// TI - Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JO - JAMA VL - 280 UR - https://doi.org/10.1001/jama.280.11.969 DO - 10.1001/jama.280.11.969 ID - D'Amico1998 ER - TY - JOUR AU - Fendler, A. AU - Stephan, C. AU - Yousef, G. M. PY - 2016 DA - 2016// TI - The translational potential of microRNAs as biofluid markers of urological tumors JO - Nat Rev Urol VL - 13 UR - https://doi.org/10.1038/nrurol.2016.193 DO - 10.1038/nrurol.2016.193 ID - Fendler2016 ER - TY - JOUR AU - Mitchell, P. S. PY - 2008 DA - 2008// TI - Circulating microRNAs as stable blood-based markers for cancer detection JO - Proc Natl Acad Sci U S A VL - 105 UR - https://doi.org/10.1073/pnas.0804549105 DO - 10.1073/pnas.0804549105 ID - Mitchell2008 ER - TY - JOUR AU - Weber, J. A. PY - 2010 DA - 2010// TI - The microRNA spectrum in 12 body fluids JO - Clin Chem VL - 56 UR - https://doi.org/10.1373/clinchem.2010.147405 DO - 10.1373/clinchem.2010.147405 ID - Weber2010 ER - TY - JOUR AU - Nunzio, C. AU - Simone, G. AU - Brassetti, A. PY - 2016 DA - 2016// TI - Metabolic syndrome is associated with advanced prostate cancer in patients treated with radical retropubic prostatectomy: results from a multicentre prospective study JO - BMC Cancer VL - 16 UR - https://doi.org/10.1186/s12885-016-2442-7 DO - 10.1186/s12885-016-2442-7 ID - Nunzio2016 ER - TY - JOUR AU - Nunzio, P. F. AU - Lombardo, R. PY - 2016 DA - 2016// TI - Physical activity as a risk factor for prostate cancer diagnosis: a prospective biopsy cohort analysis JO - BJU Int VL - 117 UR - https://doi.org/10.1111/bju.13157 DO - 10.1111/bju.13157 ID - Nunzio2016 ER - TY - JOUR AU - Panero, R. AU - Rinaldi, A. AU - Memoli, D. PY - 2017 DA - 2017// TI - iSmaRT: a toolkit for a comprehensive analysis of small RNA-Seq data JO - Bioinformatics. VL - 33 UR - https://doi.org/10.1093/bioinformatics/btx647 DO - 10.1093/bioinformatics/btx647 ID - Panero2017 ER - TY - JOUR AU - Love, M. I. AU - Huber, W. AU - Anders, S. PY - 2014 DA - 2014// TI - Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 JO - Genome Biol VL - 15 UR - https://doi.org/10.1186/s13059-014-0550-8 DO - 10.1186/s13059-014-0550-8 ID - Love2014 ER - TY - JOUR AU - Jin, Y. AU - Wong, Y. S. AU - Goh, B. K. P. PY - 2019 DA - 2019// TI - Circulating microRNAs as potential diagnostic and prognostic biomarkers in hepatocellular carcinoma JO - Sci Rep VL - 9 UR - https://doi.org/10.1038/s41598-019-46872-8 DO - 10.1038/s41598-019-46872-8 ID - Jin2019 ER - TY - JOUR AU - Cheng, G. PY - 2015 DA - 2015// TI - Circulating miRNAs: roles in cancer diagnosis, prognosis, and therapy JO - Adv Drug Deliv Rev VL - 81C UR - https://doi.org/10.1016/j.addr.2014.09.001 DO - 10.1016/j.addr.2014.09.001 ID - Cheng2015 ER - TY - JOUR AU - Chen, Z. H. AU - Zhang, G. L. AU - Li, H. R. AU - Luo, J. D. AU - Li, Z. X. AU - Chen, G. M. PY - 2012 DA - 2012// TI - A panel of five circulating microRNAs as potential biomarkers for prostate cancer JO - Prostate VL - 72 UR - https://doi.org/10.1002/pros.22495 DO - 10.1002/pros.22495 ID - Chen2012 ER - TY - JOUR AU - Srivastava, A. AU - Goldberger, H. AU - Dimtchev, A. AU - Marian, C. AU - Soldin, O. AU - Li, X. PY - 2014 DA - 2014// TI - Circulatory miR-628–5p is downregulated in prostate cancer patients JO - Tumour Biol VL - 35 UR - https://doi.org/10.1007/s13277-014-1638-1 DO - 10.1007/s13277-014-1638-1 ID - Srivastava2014 ER - TY - JOUR AU - McDonald, A. C. AU - Vira, M. AU - Shen, J. AU - Sanda, M. AU - Raman, J. D. AU - Liao, J. PY - 2018 DA - 2018// TI - Circulating microRNAs in plasma as potential biomarkers for the early detection of prostate cancer JO - Prostate VL - 78 UR - https://doi.org/10.1002/pros.23485 DO - 10.1002/pros.23485 ID - McDonald2018 ER - TY - JOUR AU - Haldrup, C. AU - Kosaka, N. AU - Ochiya, T. AU - Borre, M. AU - Hoyer, S. AU - Orntoft, T. F. PY - 2014 DA - 2014// TI - Profiling of circulating microRNAs for prostate cancer biomarker discovery JO - Drug Deliv Transl Res VL - 4 UR - https://doi.org/10.1007/s13346-013-0169-4 DO - 10.1007/s13346-013-0169-4 ID - Haldrup2014 ER - TY - JOUR AU - Moltzahn, F. AU - Olshen, A. B. AU - Baehner, L. AU - Peek, A. AU - Fong, L. AU - Stoppler, H. PY - 2011 DA - 2011// TI - Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients JO - Cancer Res VL - 71 UR - https://doi.org/10.1158/0008-5472.CAN-10-1229 DO - 10.1158/0008-5472.CAN-10-1229 ID - Moltzahn2011 ER - TY - JOUR AU - Matin, F. AU - Jeet, V. AU - Moya, L. AU - Selth, L. A. AU - Chambers, S. AU - Yeadon, T. AU - Saunders, P. AU - Eckert, A. AU - Heathcote, P. AU - Wood, G. PY - 2018 DA - 2018// TI - A plasma biomarker panel of four MicroRNAs for the diagnosis of prostate Cancer JO - Sci Rep VL - 8 UR - https://doi.org/10.1038/s41598-018-24424-w DO - 10.1038/s41598-018-24424-w ID - Matin2018 ER - TY - JOUR AU - Pashaei, E. AU - Pashaei, E. AU - Ahmady, M. AU - Ozen, M. AU - Aydin, N. PY - 2017 DA - 2017// TI - Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy JO - PLoS One VL - 12 UR - https://doi.org/10.1371/journal.pone.0179543 DO - 10.1371/journal.pone.0179543 ID - Pashaei2017 ER - TY - JOUR AU - Ni, R. AU - Huang, Y. AU - Wang, J. PY - 2015 DA - 2015// TI - miR-98 targets ITGB3 to inhibit proliferation, migration, and invasion of non-small-cell lung cancer JO - OncoTargets Ther VL - 8 ID - Ni2015 ER - TY - JOUR AU - Wang, K. AU - Dong, L. AU - Fang, Q. PY - 2017 DA - 2017// TI - Low serum miR-98 as an unfavorable prognostic biomarker in patients with non-small cell lung cancer JO - Cancer Biomark VL - 20 UR - https://doi.org/10.3233/CBM-170124) DO - 10.3233/CBM-170124) ID - Wang2017 ER - TY - JOUR AU - Li, F. AU - Li, X. J. AU - Qiao, L. PY - 2014 DA - 2014// TI - miR-98 suppresses melanoma metastasis through a negative feedback loop with its target gene IL-6 JO - Exp Mol Med VL - 46 UR - https://doi.org/10.1038/emm.2014.63 DO - 10.1038/emm.2014.63 ID - Li2014 ER - TY - STD TI - Huang SD, Yuan Y, Zhuang CW, et. al. MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma. Mol Cancer 2012;11:51. doi: https://doi.org/10.1186/1476-4598-11-51)https://doi.org/10.1186/1476-4598-11-51). ID - ref30 ER - TY - JOUR AU - Kelly, B. D. PY - 2015 DA - 2015// TI - A circulating MicroRNA signature as a biomarker for prostate cancer in a high risk group JO - J Clin Med VL - 4 UR - https://doi.org/10.3390/jcm4071369 DO - 10.3390/jcm4071369 ID - Kelly2015 ER - TY - STD TI - Cochetti G, Poli G, Guelfi G, et al. Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role. Onco Targets Ther. 2016;9:7545–7553. Published 2016 Dec 13. doi:https://doi.org/10.2147/OTT.S119027 ID - ref32 ER - TY - STD TI - Ling XH, Han ZD, Xia D et al. MicroRNA-30c serves as an independent biochemical recurrence predictor and potential tumor suppressor for prostate cancer. Mol Biol Rep. 2014;41:2779–2788). While no data are available for miRs 25-5p and 4732-3p. ID - ref33 ER -